NYSE:ELAN Elanco Animal Health (ELAN) Stock Price, News & Analysis $22.55 -0.14 (-0.62%) Closing price 03:59 PM EasternExtended Trading$22.71 +0.16 (+0.71%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Elanco Animal Health Stock (NYSE:ELAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Elanco Animal Health alerts:Sign Up Key Stats Today's Range$22.31▼$22.7650-Day Range$21.78▼$25.1152-Week Range$19.40▼$27.98Volume4.28 million shsAverage Volume5.15 million shsMarket Capitalization$11.27 billionP/E Ratio21.41Dividend YieldN/APrice Target$29.42Consensus RatingModerate Buy Company Overview Elanco Animal Health Incorporated is a global animal health company that develops, manufactures and markets products for pets and food-producing animals. Its portfolio is designed to help prevent and treat disease, control parasites and support the health and productivity of animals. The company’s products include vaccines, parasiticides, antibiotics, nutritional supplements and other prescription and over-the-counter therapies. Its companion animal offerings address conditions such as flea and tick infestations, internal parasites, osteoarthritis and dermatological disorders, while its farm animal products support the health of cattle, poultry, swine and aquaculture species. Elanco serves customers in markets around the world through relationships with veterinarians, animal owners, livestock producers, retailers and distributors. The company originated as the animal health business of Eli Lilly and became an independent, publicly traded company in 2018. In 2020, Elanco expanded its portfolio through the acquisition of Bayer Animal Health.AI Generated. May Contain Errors. Read More Elanco Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScoreELAN MarketRank™: 4.139300847455 of 5 starsElanco Animal Health scored higher than 83% of companies evaluated by MarketBeat, and ranked 100th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingElanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 1 strong buy rating, 9 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialElanco Animal Health has a consensus price target of $29.42, representing about 30.5% upside from its current price of $22.55.Amount of Analyst CoverageElanco Animal Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Elanco Animal Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth13.27% Earnings GrowthEarnings for Elanco Animal Health are expected to grow by 13.27% in the coming year, from $1.13 to $1.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elanco Animal Health is -55.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Elanco Animal Health is -55.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioElanco Animal Health has a PEG Ratio of 2.00. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioElanco Animal Health has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Elanco Animal Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.55% of the float of Elanco Animal Health has been sold short.Short Interest Ratio / Days to CoverElanco Animal Health has a short interest ratio ("days to cover") of 6.16.Change versus previous monthShort interest in Elanco Animal Health has recently increased by 17.24%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElanco Animal Health does not currently pay a dividend.Dividend GrowthElanco Animal Health does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.16 News SentimentElanco Animal Health has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Elanco Animal Health this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for ELAN on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.MarketBeat Follows5 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Cluster Insider Buying5 insiders have purchased shares of Elanco Animal Health in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $1,373,059.00 in company stock, which represents 0.0122% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Elanco Animal Health insiders have bought 1,372.37% more of their company's stock than they have sold. Specifically, they have bought $1,473,109.00 in company stock and sold $100,050.00 in company stock.Percentage Held by Insiders1.14% of the stock of Elanco Animal Health is held by insiders.Percentage Held by Institutions97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Elanco Animal Health's insider trading history. Receive ELAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELAN Stock News HeadlinesElanco Animal Health Incorporated Announces Management ChangesOctober 22 at 10:46 AM | marketscreener.comMDoes Elanco Animal Health (ELAN) Sit Below Fair Value After Zenrelia?October 22 at 10:46 AM | finance.yahoo.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 23 at 1:00 AM | Investors Alley (Ad)Elanco Animal Health Appoints Jamie Preston as Chief People OfficerOctober 22 at 7:00 AM | prnewswire.comElanco Animal Health Incorporated (NYSE:ELAN) Stock Now Rated "Moderate Buy" by Wall Street BrokeragesOctober 22 at 2:59 AM | americanbankingnews.comElanco Animal Health (NYSE:ELAN) Rating Lowered to Hold at Jefferies Financial GroupOctober 22 at 2:08 AM | americanbankingnews.comJefferies downgrades Elanco Animal Health to hold from buyOctober 21 at 5:32 PM | msn.comInsider Selling: Elanco Animal Health (NYSE:ELAN) Insider Sells 4,350 Shares of StockOctober 20 at 4:22 AM | insidertrades.comSee More Headlines ELAN Stock Analysis - Frequently Asked Questions How have ELAN shares performed this year? Elanco Animal Health's stock was trading at $22.64 at the beginning of 2026. Since then, ELAN shares have decreased by 0.4% and is now trading at $22.5490. How were Elanco Animal Health's earnings last quarter? Elanco Animal Health Incorporated (NYSE:ELAN) posted its earnings results on Wednesday, August, 5th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.07. The firm's quarterly revenue was up 10.2% compared to the same quarter last year. Read the conference call transcript. When did Elanco Animal Health IPO? Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers. Who are Elanco Animal Health's major shareholders? Top institutional shareholders of Elanco Animal Health include Artemis Investment Management LLP (0.92%), Douglas Lane & Associates LLC (0.46%), Integrated Advisors Network LLC (0.05%) and Skylands Capital LLC (0.04%). Insiders that own company stock include Lawrence Erik Kurzius, R David Hoover, Jeffrey N Simmons, Rajeev A Modi, Timothy J Bettington, Robert M Vanhimbergen, Michael J Harrington, Paul Herendeen and Shiv O'neill. View institutional ownership trends. How do I buy shares of Elanco Animal Health? Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Elanco Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Micron Technology (MU), Salesforce (CRM), Palo Alto Networks (PANW) and Bank of America (BAC). Company Calendar Last Earnings8/05/2026Today10/23/2026Next Earnings (Estimated)11/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, ELAN's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:ELAN CIK1739104 Webwww.elanco.com Phone(877) 352-6261FaxN/AEmployees9,400Year Founded1954Price Target and Rating Average Price Target for Elanco Animal Health$29.42 High Price Target$33.00 Low Price Target$24.00 Potential Upside/Downside+30.5%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($0.41) Trailing P/E RatioN/A Forward P/E Ratio19.95 P/E Growth2Net Income-$232 million Net Margins-3.96% Pretax Margin-3.31% Return on Equity8.13% Return on Assets3.99% Debt Debt-to-Equity Ratio0.58 Current Ratio2.05 Quick Ratio1.10 Sales & Book Value Annual Sales$4.72 billion Price / Sales2.39 Cash Flow$2.32 per share Price / Cash Flow9.72 Book Value$13.18 per share Price / Book1.71Miscellaneous Outstanding Shares499,620,000Free Float493,926,000Market Cap$11.27 billion OptionableOptionable Beta1.70 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:ELAN) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
